Achieve powerful penetration with
your treatment goals in mind
*IQVIA NPA Monthly. November 2018
PROLENSA® is manufactured in an FDA-approved facility that helps ensure stringent safety and quality control
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Clickhere for full Prescribing Information for PROLENSA®.